In a shabby lane of Noida’s sector 2, a non-descript building houses the India offices of a clever little company. Arcanely named i3 Nanotec, it has been using nanotechnology for Indian pharmaceutical majors. One of the big challenges that drug makers face is the high volume of chemicals which are used and then wasted during the manufacturing process.
A long-standing challenge for the industry worldwide has been to reduce and recover the input chemicals. By recovering the chemicals, the environmental impact is minimised. But it makes business sense, too, since recovering and reusing ...
TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST Rs
Key stories on business-standard.com are available to premium subscribers only.
Already a premium subscriber? LOGIN NOW
Note: Subscription will be auto renewed, you may cancel any time in the future without any questions asked.
What you get?
ON BUSINESS STANDARD DIGITAL
- Unlimited access to all the content on any device through browser or app.
- Exclusive content, features, opinions and comment – hand-picked by our editors, just for you.
- Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
- Track the industry of your choice with a daily newsletter specific to that industry.
- Stay on top of your investments. Track stock prices in your portfolio.
- 18 years of archival data.
- Requires you to share personal information like date of birth, income, location amongst other fields. This information alongwith your contact information will be shared with the partners associated with this program, who contribute towards subsidizing the offer. By subscribing to this product you acknowledge and accept that our Partners may choose to contact you with offers of their products and services.
- This is an optional offer - Not comfortable with sharing personal data - please opt for the full price offer which requires you to share minimal information